Jamie L. Reynoso
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jamie L. Reynoso
Jamie L. Reynoso is recorded as CEO and COO at Clover Health Investments, Corp. /De (CLOV). Clover Health Investments, Corp. /De reported in an 8-K filed January 10, 2023 that Jamie L. Reynoso was appointed Chief Executive Officer of Medicare Advantage, effective January 6, 2023. The proxy statement of Clover Health Investments, Corp. /De reports total compensation of $1,468,166 for Jamie L. Reynoso in fiscal 2025, including a base salary of $550,001. Disclosed compensation is on record for 5 fiscal years.
“On January 6, 2023, the Board of Directors of Clover Health Investments, Corp. (the "Company") appointed Jamie L. Reynoso Chief Executive Officer of Medicare Advantage, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Clover Health Investments, Corp. /De
Other people whose current roles at this company are on record from its filings.
- Andrew Toy CEO, Board Member
- Conrad Wai CEO, CTO
- Vivek Garipalli Chairman, Board Member
- Clay Thornton CFO
- Joseph Wagner CFO
- Gia Lee General Counsel
- Karen Soares General Counsel
- Joseph (Joe) Oldakowski Chief Accounting Officer
- Mark Herbers Chief Accounting Officer
- Anna Loengard, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $550,001 | $1,468,166 |
| 2024 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $550,000 | $4,792,147 |
| 2023 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $486,539 | $2,494,844 |
| 2022 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $440,385 | $2,929,875 |
| 2021 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $411,539 | $3,048,484 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.